Page 48 - ITPS-8-1

INNOSC Theranostics and
Pharmacological Sciences Ketamine for cocaine use disorder

doi: 10.1016/j.drugalcdep.2013.12.019 45. Park K, Volkow ND, Pan Y, Du C. Chronic cocaine
dampens dopamine signaling during cocaine intoxication
36. Dakwar E, Nunes E, Hart C, Hu M, Foltin R, Levin F. and unbalances D1 over D2 receptor signaling. J Neurosci.
A sub-set of psychoactive effects may be critical to the
behavioral impact of ketamine on cocaine use disorder: 2013;33(40):15827-15836.
Results from a randomized, controlled laboratory study. doi: 10.1523/JNEUROSCI.1935-13.2013
Neuropharmacology. 2018;142:270-276. 46. Kaushik S, Ahmad F, Choudhary S, et al. Critical appraisal
doi: 10.1016/j.neuropharm.2018.01.005 and systematic review of genes linked with cocaine
addiction, depression and anxiety. Neurosci Biobehav Rev.
37. Chan B, Kondo K, Freeman M, Ayers C, Montgomery J, 2023;152:105270.
Kansagara D. Pharmacotherapy for cocaine use disorder-a
systematic review and meta-analysis. J Gen Intern Med. doi: 10.1016/j.neubiorev.2023.105270
2019;34(12):2858-2873. 47. Dackis CA, Gold MS. New concepts in cocaine addiction:
doi: 10.1007/s11606-019-05074-8 The dopamine depletion hypothesis. Neurosci Biobehav Rev.
1985;9(3):469-477.
38. Angarita GA, Hadizadeh H, Cerdena I, Potenza MN. Can
pharmacotherapy improve treatment outcomes in people with doi: 10.1016/0149-7634(85)90022-3
co-occurring major depressive and cocaine use disorders? 48. Volkow ND, Tomasi D, Wang GJ, et al. Stimulant-induced
Expert Opin Pharmacother. 2021;22(13):1669-1683. dopamine increases are markedly blunted in active cocaine
doi: 10.1080/14656566.2021.1931684 abusers. Mol Psychiatry. 2014;19(9):1037-1043.
39. Carey TL. Use of antidepressants in patients with doi: 10.1038/mp.2014.58
co-occurring depression and substance use disorders. In: 49. Cui L, Li S, Wang S, et al. Major depressive disorder:
Macaluso M, Preskorn SH, editors. Antidepressants: From Hypothesis, mechanism, prevention and treatment. Signal
Biogenic Amines to New Mechanisms of Action. Berlin: Transduct Target Ther. 2024;9(1):1-32.
Springer International Publishing; 2019. p. 359-370.
doi: 10.1038/s41392-024-01738-y
doi: 10.1007/164_2018_162
50. Deng J, Zhang T, Zheng X, Shang L, Zhan CG, Zheng F.
40. Aharonovich E, Scodes J, Wall MM, Hasin DS. The Recovery of dopaminergic system after cocaine exposure
relationship of frequency of cocaine use to substance and and impact of a long-acting cocaine hydrolase. Addict Biol.
psychiatric disorders in the U.S. general population. Drug 2022;27(4):e13179.
Alcohol Depend. 2021;227:108933. doi: 10.1111/adb.13179
doi: 10.1016/j.drugalcdep.2021.108933 51. Belujon P, Grace AA. Restoring mood balance in depression:
41. Samet S, Fenton MC, Nunes E, Greenstein E, Aharonovich E, Ketamine reverses deficit in dopamine-dependent synaptic
Hasin D. Effects of independent and substance-induced plasticity. Biol Psychiatry. 2014;76(12):927-936.
major depressive disorder on remission and relapse of doi: 10.1016/j.biopsych.2014.04.014
alcohol, cocaine and heroin dependence. Addiction.
2013;108(1):115-123. 52. Witkin JM, Monn JA, Schoepp DD, et al. The rapidly
acting antidepressant ketamine and the mGlu2/3 receptor
doi: 10.1111/j.1360-0443.2012.04010.x antagonist LY341495 rapidly engage dopaminergic mood
42. Zilkha N, Barnea-Ygael N, Keidar L, Zangen A. Increased circuits. J Pharmacol Exp Ther. 2016;358(1):71-82.
relapse to cocaine-seeking in a genetic model for depression. doi: 10.1124/jpet.116.233627
Addict Biol. 2020;25(3):e12756.
53. Li Y, Zhu ZR, Ou BC, et al. Dopamine D2/D3 but
doi: 10.1111/adb.12756 not dopamine D1 receptors are involved in the rapid
43. Cabé J, Brousse G, Pereira B, et al. Influence of clinical antidepressant-like effects of ketamine in the forced swim
markers of dopaminergic behaviors on depressive symptoms test. Behav Brain Res. 2015;279:100-105.
during withdrawal in cocaine users. Front Psychiatry. doi: 10.1016/j.bbr.2014.11.016
2021;12:775670.
54. Li X jin, Yu J han, Wu X, et al. Ketamine enhances
doi: 10.3389/fpsyt.2021.775670 dopamine D1 receptor expression by modulating
microRNAs in a ketamine-induced schizophrenia-like
44. Tobón KE, Catuzzi JE, Cote SR, Sonaike A, Kuzhikandathil EV.
Post-transcriptional regulation of dopamine D1 receptor mouse model. Neurotoxicol Teratol. 2022;91:107079.
expression in caudate-putamen of cocaine-sensitized mice. doi: 10.1016/j.ntt.2022.107079
Eur J Neurosci. 2015;42(2):1849-1857.
55. Hare BD, Shinohara R, Liu RJ, Pothula S, DiLeone RJ,
doi: 10.1111/ejn.12933 Duman RS. Optogenetic stimulation of medial prefrontal

Volume 8 Issue 1 (2025) 42 doi: 10.36922/itps.4458